Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sangeetha Murugapandian

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Current Cardiology Reports|March 3, 2021
Glucose-Lowering Medications and Cardiovascular OutcomesMadhan Shanmugasundaram, J R Exequiel Pineda, Sangeetha Murugapandian
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|July 14, 2023
Contemporary Monoclonal Antibody Utilization in Glomerular DiseasesIyad Mansour, Sangeetha Murugapandian, Bekir Tanriover, et al.
Clinics and Practice|January 9, 2015
Outcome of Patients with Infective Endocarditis who were Treated with Extracorporeal Membrane Oxygenation and Continuous Renal Replacement TherapySanthosh G John, Preethi William, Sangeetha Murugapandian, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 10, 2024
Viral Nephropathies: Core Curriculum 2024Amy A Yau, Sangeetha Murugapandian, Ali W Rizvi, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|May 7, 2018
Drug-coated balloon in peripheral artery diseaseMadhan Shanmugasundaram, Sangeetha Murugapandian, Huu Tam Truong, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 12, 2019
Outcomes of Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention Analysis of National Inpatient SampleMadhan Shanmugasundaram, Bishnu P Dhakal, Sangeetha Murugapandian, et al.
Case Reports in Nephrology and Dialysis|August 13, 2015
Improvement in Gemcitabine-Induced Thrombotic Microangiopathy with Rituximab in a Patient with Ovarian Cancer: Mechanistic ConsiderationsSangeetha Murugapandian, Babitha Bijin, Iyad Mansour, et al.
Medicine|May 6, 2016
Epidemiology of Glomerular Disease in Southern Arizona: Review of 10-Year Renal Biopsy DataSangeetha Murugapandian, Iyad Mansour, Mohammad Hudeeb, et al.
The American Journal of Medicine|March 10, 2023
The Impact of Nirmatrelvir-Ritonavir in Reducing Hospitalizations Among High-Risk Patients With SARS-CoV-2 During the Omicron Predominant EraMohanad M Al-Obaidi, Ahmet B Gungor, Sangeetha Murugapandian, et al.
Plos One|April 28, 2023
Lack of effectiveness of Bebtelovimab monoclonal antibody among high-risk patients with SARS-Cov-2 Omicron during BA.2, BA.2.12.1 and BA.5 subvariants dominated eraSrilekha Sridhara, Ahmet B Gungor, Halil K Erol, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Cardiology Reports|March 3, 2021
Glucose-Lowering Medications and Cardiovascular OutcomesMadhan Shanmugasundaram, J R Exequiel Pineda, Sangeetha Murugapandian
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|July 14, 2023
Contemporary Monoclonal Antibody Utilization in Glomerular DiseasesIyad Mansour, Sangeetha Murugapandian, Bekir Tanriover, et al.
Clinics and Practice|January 9, 2015
Outcome of Patients with Infective Endocarditis who were Treated with Extracorporeal Membrane Oxygenation and Continuous Renal Replacement TherapySanthosh G John, Preethi William, Sangeetha Murugapandian, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 10, 2024
Viral Nephropathies: Core Curriculum 2024Amy A Yau, Sangeetha Murugapandian, Ali W Rizvi, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|May 7, 2018
Drug-coated balloon in peripheral artery diseaseMadhan Shanmugasundaram, Sangeetha Murugapandian, Huu Tam Truong, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 12, 2019
Outcomes of Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention Analysis of National Inpatient SampleMadhan Shanmugasundaram, Bishnu P Dhakal, Sangeetha Murugapandian, et al.
Case Reports in Nephrology and Dialysis|August 13, 2015
Improvement in Gemcitabine-Induced Thrombotic Microangiopathy with Rituximab in a Patient with Ovarian Cancer: Mechanistic ConsiderationsSangeetha Murugapandian, Babitha Bijin, Iyad Mansour, et al.
Medicine|May 6, 2016
Epidemiology of Glomerular Disease in Southern Arizona: Review of 10-Year Renal Biopsy DataSangeetha Murugapandian, Iyad Mansour, Mohammad Hudeeb, et al.
The American Journal of Medicine|March 10, 2023
The Impact of Nirmatrelvir-Ritonavir in Reducing Hospitalizations Among High-Risk Patients With SARS-CoV-2 During the Omicron Predominant EraMohanad M Al-Obaidi, Ahmet B Gungor, Sangeetha Murugapandian, et al.
Plos One|April 28, 2023
Lack of effectiveness of Bebtelovimab monoclonal antibody among high-risk patients with SARS-Cov-2 Omicron during BA.2, BA.2.12.1 and BA.5 subvariants dominated eraSrilekha Sridhara, Ahmet B Gungor, Halil K Erol, et al.
Pageof 2